CLINICAL_TRIALS ClinicalTrials.gov record update

TACE Combined With Sorafenib and PD-1 mAb in the Treatment of BCLC B/C Hepatocellular Carcinoma: Single Arm, Single Center, Open Label Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04518852
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:25.974986+00:00
Published At: 2024-06-25T00:00:00+00:00
Record Updated At: 2024-06-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatocellular Carcinoma", "Liver Neoplasms", "Digestive System Neoplasms", "Sorafenib", "Molecular Mechanisms of Pharmacological Action", "Liver Diseases", "Antineoplastic Agents", "Protein Kinase Inhibitors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-06-25"
protocolSection.identificationModule.nctId: "NCT04518852"
protocolSection.identificationModule.officialTitle: "TACE Combined With Sorafenib and PD-1 mAb in the Treatment of BCLC B/C Hepatocellular Carcinoma: Single Arm, Single Center, Open Label Study"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.